The Arvix BioMatrix™
Platform
A focused portfolio of regenerative matrices designed to provide consistent configurations, predictable handling, and documentation alignment for use within hospital clinical programs.
Regenerative matrices for clinical care
The Arvix BioMatrix™ platform is a focused portfolio of regenerative matrices, including placental-derived amniotic membranes and collagen-based wound matrices. The platform is designed to provide consistent configurations, predictable handling, and documentation alignment for use within hospital clinical programs.
Unified Framework
All products developed within a unified regulatory and quality framework to support institutional evaluation and standardization.
Multiple Configurations
Dual-layer and single-layer amniotic membranes plus collagen powder formulation to address diverse clinical needs.
Documentation Ready
Comprehensive documentation package designed to support hospital value analysis and procurement processes.
BioMatrix™ Core
A dual-layer placental-derived amniotic membrane matrix designed to provide enhanced structural integrity and predictable handling for institutional clinical use.
Product Features
Dual-layer amniotic membrane configuration
Tissue-based extracellular matrix scaffold
Processed to preserve native membrane architecture
Designed for predictable handling in clinical settings
Positioned for hospital evaluation and adoption
Specifications
Multiple size configurations available
Room temperature storage
Extended shelf life
UDI-ready labeling
BioMatrix™ Base
A single-layer placental-derived amniotic membrane matrix offering a foundational configuration for broad clinical applicability within hospital settings.
Product Features
Single-layer amniotic membrane configuration
Core platform option for routine regenerative applications
Clear regulatory positioning
Designed to integrate into hospital workflows and procurement models
Specifications
Standard size options
Ambient storage conditions
Consistent shelf life
Compliant labeling
BioMatrix™ Prime
A collagen-based wound matrix powder designed to support wound management across a range of clinical environments.
Product Features
Collagen powder formulation for wound applications
Designed for ease of application and clinical handling
Positioned for institutional evaluation and hospital use
Part of the broader Arvix BioMatrix™ regenerative platform
Specifications
Powder formulation for versatile application
Room temperature storage
Extended shelf life
UDI-ready labeling
Platform advantages
The unified BioMatrix™ platform approach provides institutional benefits beyond individual product features.
Standardization Potential
Multiple product configurations within a single regulatory and quality framework enable hospitals to standardize regenerative tissue procurement.
Procurement Efficiency
Unified documentation package and vendor relationship streamline hospital evaluation, contracting, and ordering processes.
Clinical Flexibility
Range of configurations allows clinical teams to select appropriate matrix type based on specific wound characteristics and clinical needs.
Quality Consistency
All products manufactured under the same quality management system with consistent processing standards and traceability protocols.